Floatz logo

H.P. Acthar Gel

Multiple Sclerosis (MS)

The University of Texas Health Science Center, Houstonprotein_peptidePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Multiple Sclerosis (MS) cohort.

Asset / SponsorPhaseRating
Repository Corticotropin
The University of Texas Health Science Center, Houston
Phase 4BB
MODERNA COVID-19 VACCINE RNA
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
JNJ-78436735
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
Medroxyprogesterone acetate
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
Monovalent [B.1.351] Cov2 Pres Dtm-As03
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC

View all 15 →

Same molecule, other indications

H.P. Acthar Gel is also rated in:

Chronic MigraineDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →